Hypomethylating Agents vs. Stem Cell Transplant: Forecast 2028

добавлена новая статья Другое

2026-01-09 16:33:01 -

The global myelodysplasia treatment market is witnessing consistent growth due to the increasing prevalence of myelodysplastic syndromes (MDS), rising geriatric population, and rapid advancements in hematology diagnostics and therapeutic innovations. Myelodysplasia is a group of bone marrow disorders characterized by ineffective blood cell production, often progressing to acute...

0 Комментарии 0 Поделились 160 Просмотры 0 предпросмотр